Sangtec licenses DxS's DNA detection technology:
This article was originally published in Clinica
Executive Summary
Sangtec Molecular Diagnostics, based near Stockholm, Sweden, has licensed a fluorescence-based DNA detection and genotyping system developed by Manchester, UK-based DxS. The technology, called Scorpions, will be used in the development of new polymerase chain reaction (PCR) tests within Sangtec's focus areas of cancer and infectious disease.